Etzer Darout

Stock Analyst at BMO Capital

(1.91)
# 2,975
Out of 4,840 analysts
111
Total ratings
32.14%
Success rate
-6.99%
Average return

Stocks Rated by Etzer Darout

Terns Pharmaceuticals
May 13, 2025
Maintains: Outperform
Price Target: $26$15
Current: $3.01
Upside: +398.34%
Verve Therapeutics
Apr 15, 2025
Maintains: Buy
Price Target: $18$24
Current: $4.29
Upside: +459.44%
Inventiva
Apr 4, 2025
Maintains: Buy
Price Target: $12$9
Current: $3.36
Upside: +167.86%
Arvinas
Mar 12, 2025
Maintains: Outperform
Price Target: $82$20
Current: $6.69
Upside: +198.95%
Protagonist Therapeutics
Mar 11, 2025
Reiterates: Outperform
Price Target: $62$72
Current: $46.43
Upside: +55.07%
BioNTech SE
Mar 11, 2025
Maintains: Outperform
Price Target: $130$143
Current: $98.55
Upside: +45.10%
Q32 Bio
Feb 11, 2025
Downgrades: Market Perform
Price Target: $22$3
Current: $1.68
Upside: +78.57%
IGM Biosciences
Jan 10, 2025
Downgrades: Market Perform
Price Target: $21$2
Current: $1.22
Upside: +63.93%
Exelixis
Dec 20, 2024
Downgrades: Market Perform
Price Target: $36$40
Current: $43.09
Upside: -7.17%
Tourmaline Bio
Dec 6, 2024
Initiates: Outperform
Price Target: $50
Current: $15.50
Upside: +222.58%
Initiates: Outperform
Price Target: $35
Current: $9.77
Upside: +258.24%
Initiates: Market Perform
Price Target: $55
Current: $28.11
Upside: +95.69%
Initiates: Outperform
Price Target: $63
Current: $4.77
Upside: +1,220.75%
Maintains: Outperform
Price Target: $28$27
Current: $1.10
Upside: +2,354.55%
Maintains: Outperform
Price Target: $132$134
Current: $72.27
Upside: +85.42%
Reiterates: Outperform
Price Target: $32$34
Current: $7.75
Upside: +338.71%
Reiterates: Outperform
Price Target: $46$48
Current: $21.28
Upside: +125.56%
Maintains: Market Perform
Price Target: $118$120
Current: $113.21
Upside: +6.00%
Maintains: Outperform
Price Target: $34$38
Current: $30.46
Upside: +24.75%
Maintains: Outperform
Price Target: $26$25
Current: $4.41
Upside: +466.89%
Maintains: Market Perform
Price Target: $8$5
Current: $1.49
Upside: +236.70%
Reiterates: Outperform
Price Target: $20
Current: $1.30
Upside: +1,438.46%
Maintains: Outperform
Price Target: $84$91
Current: $50.80
Upside: +79.13%
Maintains: Market Perform
Price Target: $7$6
Current: $1.22
Upside: +391.80%
Maintains: Market Perform
Price Target: $3.25$3.59
Current: $2.13
Upside: +68.94%
Maintains: Outperform
Price Target: $80$82
Current: $70.96
Upside: +15.56%
Maintains: Outperform
Price Target: $20$19
Current: $4.03
Upside: +371.46%
Upgrades: Buy
Price Target: $170
Current: $290.10
Upside: -41.40%
Initiates: Buy
Price Target: $54
Current: $46.00
Upside: +17.39%
Maintains: Buy
Price Target: $27$38
Current: $43.87
Upside: -13.38%
Maintains: Outperform
Price Target: $54$52
Current: $1.27
Upside: +3,994.49%